Redbiotec AG

CONSULTING / INTERIM MANAGEMENT (a Capricorn Consilium Project)

Wanted: experienced Business Developer for a biotech company in the field of Virus-Like Particles (VLPs).

The Client

Redbiotec is a privately held Swiss Biopharmaceutical Company, based in Zurich-Schlieren. Founded in 2006 as a spin-off of the ETH Zurich, the company won several awards, including the renown W.A. De Vigier award.

Redbiotec uses its proprietary rePAX® co-expression technology for the efficient generation of multi-component virus-like particles (VLPs) and other protein assemblies. The company entered the field of VLP vaccines in 2008 and currently has a pipeline in the areas of CMV, HPV and Influenza. Besides developing its own prophylactic VLP vaccine pipeline, the company also offers customized solutions in Biologics to selected Partners.

The Assignment

The person in charge of business development took a scheduled time-out. To bridge the gap, Redbiotec was looking for a senior manager familiar with the industry who could take over with a short ramp-up.  The focus in vaccines was on driving the relationship with global players and checking the opportunities in China. In addition, contacts to companies active in the field of development of monoclonal antibodies were supposed to be intensified to identify new opportunities.

The Solution

Existing contacts to the relevant people in vaccines were helpful in reviving and intensifying the exchange, which led in at least on case to a contractual agreement. Potential Chinese partners were identified and evaluated. The number of business contacts to developers of monoclonal antibodies was increased significantly, which resulted in a bundle of new business opportunities. Internal staff took over as scheduled.